|
|
[资源]
EBR 2017 Full
The European Biopharmaceutical Review (EBR), is a journal designed to fill a unique position in scientific publishing. Published quarterly, it provides a dedicated platform of communication and information for the pan European biopharmaceutical market across Europe, North America & the rest of the developed world. The editorial covers in-depth articles, case studies, meeting and report reviews written by specialists with "hands-on" experience in the biopharmaceutical industry, traditional multi-national pharmaceutical companies, investment houses and industry-associated governmental, economic and societal bodies. Each quarterly edition examines topical areas of importance across the board of biopharmaceutical research and development, with 'regular feature sections on: Biobusiness, Science and Innovation, Biodiscovery, Biodevelopment, Biomanufacturing plus special focuses on geographic or therapeutic territories. Established in 1997, EBR is now well-recognised for providing beneficial information to players in the bio-industry including entrepreneurial biopharmaceutical and more general life science companies, large pharma companies, supplier groups, regulators, investors, analysts and consultants, thus providing a unique forum for general review of the European life science sector on a regular basis.![EBR 2017 Full]()
0998233692.png
![EBR 2017 Full-1]()
1394751756.png |
» 本帖附件资源列表
» 猜你喜欢
各位基础老师们,看完中央《从严治党》的决定后,对学术界更加有信心了吧
已经有3人回复
售SCI一区T0P文章,我:8O.55.1.O.5.4,科目齐全,可+急
已经有5人回复
售SCI一区T0P文章,我:8.O55.1.O.54,科目全,可十急
已经有6人回复
售一区SCI文章T0P,我:8O.551.O54,科目全,可十急
已经有7人回复
售SCI一区T0P文章,我:8.O.55.1.O54,科目全,可伽急
已经有6人回复
售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急
已经有10人回复
售SCI一区文章,我:8.O.55.1.O.54,科目齐全,可伽急
已经有9人回复
售SCI一区T0P文章,我:8.O55.1.O.54,科目全,可十急
已经有8人回复
售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急
已经有8人回复
售SCI一区文章,我:8.O.55.1.O.54,科目齐全,可伽急
已经有5人回复
|